Chronic Inflammatory Demyelinating Polyneuropathy Treatments
Find Chronic Inflammatory Demyelinating Polyneuropathy Treatments
Medications for Chronic Inflammatory Demyelinating Polyneuropathy
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Chronic Inflammatory Demyelinating Polyneuropathy.
Found 1 Approved Drug for Chronic Inflammatory Demyelinating Polyneuropathy
Efgartigimod
Brand Names
Vyvgart, VYVGART Hytrulo
Efgartigimod
Brand Names
Vyvgart, VYVGART Hytrulo
Form: Injection
Method of administration: Subcutaneous, Intravenous
FDA approval date: December 17, 2021
Classification: Endoglycosidase
VYVGART is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). VYVGART is a neonatal Fc receptor blocker indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances